| scholarly article | Q13442814 |
| P50 | author | Yehuda Shoenfeld | Q1515807 |
| P2093 | author name string | Aaron Lerner | |
| Torsten Matthias | |||
| P2860 | cites work | Anti-hypertensive peptides released from milk proteins by probiotics | Q90513065 |
| Effect of a Probiotic Preparation on Ventilator-Associated Pneumonia in Critically Ill Patients Admitted to the Intensive Care Unit: A Prospective Double-Blind Randomized Controlled Trial | Q90834534 | ||
| Microbial modulation of the gut microbiome for treating autoimmune diseases | Q91148861 | ||
| Antibiotic resistance, biochemical typing, and PFGE typing of Bifidobacterium strains commonly used in probiotic health foods | Q91833665 | ||
| Current Perspectives and Mechanisms of Relationship between Intestinal Microbiota Dysfunction and Dementia: A Review | Q93353557 | ||
| Probiotics for Symptoms of Depression and Anxiety | Q95522006 | ||
| Antibiotic resistance genes in the bacteriophage DNA fraction of human fecal samples | Q41772511 | ||
| Assessing the Risk of Probiotic Dietary Supplements in the Context of Antibiotic Resistance | Q41821579 | ||
| The Variable Regions of Lactobacillus rhamnosus Genomes Reveal the Dynamic Evolution of Metabolic and Host-Adaptation Repertoires | Q41950562 | ||
| Detection of antibiotic resistance in probiotics of dietary supplements. | Q41967862 | ||
| The last two millennias echo-catastrophes are the driving forces for the potential genetic advantage mechanisms in celiac disease | Q41980813 | ||
| Functional screening of antibiotic resistance genes from a representative metagenomic library of food fermenting microbiota | Q42037679 | ||
| Probiotic Microorganisms: A Closer Look | Q42333986 | ||
| Molecular characterization of a plasmid-borne (pGT633) erythromycin resistance determinant (ermGT) from Lactobacillus reuteri 100-63. | Q42605272 | ||
| Molecular characterization of a plasmid-borne (pTC82) chloramphenicol resistance determinant (cat-TC) from Lactobacillus reuteri G4. | Q42645875 | ||
| Could bacteriophages transfer antibiotic resistance genes from environmental bacteria to human-body associated bacterial populations? | Q42928316 | ||
| Abortive infection mechanisms and prophage sequences significantly influence the genetic makeup of emerging lytic lactococcal phages. | Q42957314 | ||
| Caveat emptor. "Probiotics" might not be what they seem. | Q42974249 | ||
| Role of probiotics as memory enhancer | Q43111680 | ||
| Susceptibility to tetracycline and erythromycin of Lactobacillus paracasei strains isolated from traditional Italian fermented foods | Q43224099 | ||
| Transferability of a tetracycline resistance gene from probiotic Lactobacillus reuteri to bacteria in the gastrointestinal tract of humans. | Q43226861 | ||
| A case of D-lactic acid encephalopathy associated with use of probiotics | Q43241107 | ||
| Urinary D-lactate excretion in infants receiving Lactobacillus johnsonii with formula | Q43549712 | ||
| Identification and characterization of antibiotic resistance genes in Lactobacillus reuteri and Lactobacillus plantarum. | Q46003879 | ||
| The therapeutic effect of probiotics on rheumatoid arthritis: a systematic review and meta-analysis of randomized control trials | Q46463927 | ||
| Stable Engraftment of Bifidobacterium longum AH1206 in the Human Gut Depends on Individualized Features of the Resident Microbiome | Q46483419 | ||
| Culture-dependent and culture-independent qualitative analysis of probiotic products claimed to contain bifidobacteria | Q46578797 | ||
| Role of Probiotics in Crohn's Disease and in Pouchitis | Q46657802 | ||
| Prion-Like Domains in Phagobiota | Q46756184 | ||
| A probiotic Lactobacillus strain can acquire vancomycin resistance during digestive transit in mice | Q46934918 | ||
| Revisiting Antibiotic Resistance Spreading in Wastewater Treatment Plants - Bacteriophages as a Much Neglected Potential Transmission Vehicle | Q47137352 | ||
| Effects of probiotics on body weight, body mass index, fat mass and fat percentage in subjects with overweight or obesity: a systematic review and meta-analysis of randomized controlled trials | Q47181222 | ||
| The efficacy of probiotic supplementation in rheumatoid arthritis: a meta-analysis of randomized, controlled trials | Q47206984 | ||
| The Gut Microbiome Feelings of the Brain: A Perspective for Non-Microbiologists | Q47310400 | ||
| Eliciting adverse effects data from participants in clinical trials | Q47553300 | ||
| Probiotic intervention influences the salivary levels of Matrix Metalloproteinase (MMP)-9 and Tissue Inhibitor of metalloproteinases (TIMP)-1 in healthy adults | Q47796344 | ||
| Probiotics and infective endocarditis in patients with hereditary hemorrhagic telangiectasia: a clinical case and a review of the literature. | Q48121566 | ||
| Potential Effects of Horizontal Gene Exchange in the Human Gut. | Q49258334 | ||
| Antibiotic Resistance Genetic Markers and Integrons in White Soft Cheese: Aspects of Clinical Resistome and Potentiality of Horizontal Gene Transfer. | Q49798237 | ||
| Gut microbiota and probiotics: novel immune system modulators in myasthenia gravis? | Q50010788 | ||
| Investigation of probiotics in multiple sclerosis | Q50146310 | ||
| Antibiotic resistance in probiotic bacteria | Q21131122 | ||
| Probiotics for the prevention of pediatric antibiotic-associated diarrhea | Q24186991 | ||
| Probiotics in infants for prevention of allergic disease and food hypersensitivity | Q24243561 | ||
| Novel transglutaminase-like peptidase and C2 domains elucidate the structure, biogenesis and evolution of the ciliary compartment | Q24614447 | ||
| Removal of antibiotic resistance gene-carrying plasmids from Lactobacillus reuteri ATCC 55730 and characterization of the resulting daughter strain, L. reuteri DSM 17938 | Q24653911 | ||
| Probiotics in dietary guidelines and clinical recommendations outside the European Union | Q26824061 | ||
| Update on antibiotic resistance in foodborne Lactobacillus and Lactococcus species | Q26866384 | ||
| Addressing the Antibiotic Resistance Problem with Probiotics: Reducing the Risk of Its Double-Edged Sword Effect | Q28073861 | ||
| Risk and safety of probiotics | Q28087466 | ||
| Probiotics, prebiotics, and synbiotics | Q28279222 | ||
| Bacteriophages and dairy fermentations | Q28392390 | ||
| Gut to brain interaction in Autism Spectrum Disorders: a randomized controlled trial on the role of probiotics on clinical, biochemical and neurophysiological parameters | Q28829153 | ||
| Probiotic supplementation can positively affect anxiety and depressive symptoms: a systematic review of randomized controlled trials | Q30245338 | ||
| Characterization of a new virulent phage (MLC-A) of Lactobacillus paracasei. | Q33246722 | ||
| Cycle inhibiting factors (CIFs) are a growing family of functional cyclomodulins present in invertebrate and mammal bacterial pathogens | Q33420828 | ||
| Probiotic engineering: towards development of robust probiotic strains with enhanced functional properties and for targeted control of enteric pathogens. | Q33651733 | ||
| A Functional Metagenomic Analysis of Tetracycline Resistance in Cheese Bacteria | Q33720376 | ||
| Classification and quantification of bacteriophage taxa in human gut metagenomes | Q33801728 | ||
| Microbiota and Probiotics in Health and HIV Infection. | Q33852108 | ||
| A superfamily of archaeal, bacterial, and eukaryotic proteins homologous to animal transglutaminases | Q33871440 | ||
| Molecular screening of Enterococcus virulence determinants and potential for genetic exchange between food and medical isolates. | Q33989292 | ||
| Prophylactic and therapeutic uses of probiotics: a review | Q34197047 | ||
| Polymorphic toxin systems: Comprehensive characterization of trafficking modes, processing, mechanisms of action, immunity and ecology using comparative genomics | Q34283923 | ||
| Possible association between celiac disease and bacterial transglutaminase in food processing: a hypothesis | Q34481156 | ||
| Probiotics: potential pharmaceutical applications | Q34501914 | ||
| Safety assessment of probiotics for human use. | Q34503589 | ||
| The industrial food additive, microbial transglutaminase, mimics tissue transglutaminase and is immunogenic in celiac disease patients | Q34540580 | ||
| Transglutaminases in Dysbiosis As Potential Environmental Drivers of Autoimmunity | Q34550784 | ||
| Antimicrobial activity, antibiotic susceptibility and virulence factors of Lactic Acid Bacteria of aquatic origin intended for use as probiotics in aquaculture. | Q34561402 | ||
| Clinical indications for probiotics: an overview | Q34586857 | ||
| Meta-analysis: targeting the intestinal microbiota in prophylaxis for post-operative Crohn's disease. | Q34615496 | ||
| Culture-independent analysis of probiotic products by denaturing gradient gel electrophoresis | Q34876636 | ||
| Probiotics in the third millennium | Q34984673 | ||
| Association between funding source, methodological quality and research outcomes in randomized controlled trials of synbiotics, probiotics and prebiotics added to infant formula: a systematic review | Q35039235 | ||
| Supra-organismal interactions in the human intestine. | Q35162834 | ||
| Fate, activity, and impact of ingested bacteria within the human gut microbiota | Q35594959 | ||
| Novel probiotic Bifidobacterium longum subsp. infantis CECT 7210 strain active against rotavirus infections | Q35599181 | ||
| Functional and Structural Characterization of the Antiphagocytic Properties of a Novel Transglutaminase from Streptococcus suis. | Q35905346 | ||
| Viral immunity. Transkingdom control of viral infection and immunity in the mammalian intestine | Q35905803 | ||
| Alterations in fecal microbiota composition by probiotic supplementation in healthy adults: a systematic review of randomized controlled trials | Q36012463 | ||
| In Situ Electron Microscopy of Lactomicroselenium Particles in Probiotic Bacteria | Q36067424 | ||
| Gut microorganisms, mammalian metabolism and personalized health care | Q36094303 | ||
| Phage abortive infection in lactococci: variations on a theme | Q36175317 | ||
| D-lactate in human and ruminant metabolism | Q36179015 | ||
| Liver abscess and bacteremia caused by lactobacillus: role of probiotics? Case report and review of the literature | Q36198110 | ||
| D-lactic acidosis | Q36321502 | ||
| The biology of lantibiotics from the lacticin 481 group is coming of age. | Q36649810 | ||
| Probiotics--the friendly bacteria with market potential in global market | Q36751453 | ||
| Predictable and unpredictable evolution of antibiotic resistance | Q37132323 | ||
| What a difference a Dalton makes: bacterial virulence factors modulate eukaryotic host cell signaling systems via deamidation | Q37264197 | ||
| Characterization of Bacillus probiotics available for human use | Q37315066 | ||
| Bacteriophages of lactobacillus | Q37410161 | ||
| Probiotics for preventive health | Q37423648 | ||
| Expression of prophage-encoded endolysins contributes to autolysis of Lactococcus lactis | Q37595109 | ||
| Probiotics for prevention of urinary stones | Q37634461 | ||
| Microbial flora, probiotics, Bacillus subtilis and the search for a long and healthy human longevity | Q37733445 | ||
| Impacts of microbiome metabolites on immune regulation and autoimmunity. | Q52325276 | ||
| The long and latent road to autoimmunity. | Q52724834 | ||
| Systematic review and meta-analysis investigating the efficacy and safety of probiotics in people with cancer. | Q52801554 | ||
| Yoghurt and probiotic bacteria in dietary guidelines of the member states of the European Union. | Q53632775 | ||
| The cell aggregating propensity of probiotic actinobacterial isolates: isolation and characterization of the aggregation inducing peptide pheromone. | Q53801977 | ||
| Current understanding of microbiota- and dietary-therapies for treating inflammatory bowel disease. | Q54264376 | ||
| The Present and Future of Whole Genome Sequencing (WGS) and Whole Metagenome Sequencing (WMS) for Surveillance of Antimicrobial Resistant Microorganisms and Antimicrobial Resistance Genes across the Food Chain. | Q54933866 | ||
| Prophylactic probiotics for cancer therapy-induced diarrhoea: a meta-analysis. | Q54982076 | ||
| Probiotic Species in the Modulation of Gut Microbiota: An Overview. | Q55027051 | ||
| Randomized, double-blind, placebo-controlled trial of probiotics for primary prevention: no clinical effects of Lactobacillus GG supplementation. | Q55049062 | ||
| Anaphylactic reaction to probiotics. Cow's milk and hen's egg allergens in probiotic compounds. | Q55056656 | ||
| Brain fogginess, gas and bloating: a link between SIBO, probiotics and metabolic acidosis. | Q55219396 | ||
| Effect of administration of a probiotic preparation on gut microbiota and immune response in healthy women in India: an open-label, single-arm pilot study. | Q55363098 | ||
| The anxiolytic effect of probiotics: A systematic review and meta-analysis of the clinical and preclinical literature. | Q55490879 | ||
| Bacteriophages as New Human Viral Pathogens. | Q55611171 | ||
| Bacteriophages: Protagonists of a Post-Antibiotic Era | Q56888912 | ||
| Global Survey of Antibiotic Resistance Genes in Air | Q57046113 | ||
| Are probiotics and prebiotics effective in the prevention of travellers' diarrhea: A systematic review and meta-analysis | Q57065783 | ||
| Systematic review and meta-analysis of the effect of probiotic supplementation on functional constipation in children | Q57128281 | ||
| Probiotics in Disease Prevention and Treatment | Q57141422 | ||
| Prokaryotic horizontal gene transfer within the human holobiont: ecological-evolutionary inferences, implications and possibilities | Q57156391 | ||
| Probiotics supplementation in children with asthma: A systematic review and meta-analysis | Q57164947 | ||
| The Human Gut Microbiome - A Potential Controller of Wellness and Disease | Q57169434 | ||
| A Pilot Randomized Controlled Trial to Explore Cognitive and Emotional Effects of Probiotics in Fibromyalgia | Q57210305 | ||
| Efficacy of probiotics on anxiety-A meta-analysis of randomized controlled trials | Q57406717 | ||
| Filling the Gaps: Current Research Directions for a Rational Use of Probiotics in Preterm Infants | Q57478925 | ||
| Does the medical literature remain inadequately described despite having reporting guidelines for 21 years? - A systematic review of reviews: an update | Q57491117 | ||
| Probiotics in human health and disease: from nutribiotics to pharmabiotics | Q57784013 | ||
| Probiotics in Autoimmune and Inflammatory Disorders | Q57812807 | ||
| Effect of prebiotic and probiotic supplementation on neurodevelopment in preterm very low birth weight infants: findings from a meta-analysis | Q57812828 | ||
| Do probiotics, prebiotics and synbiotics affect adiponectin and leptin in adults? A systematic review and meta-analysis of clinical trials | Q57815330 | ||
| Immunological Tolerance and Function: Associations Between Intestinal Bacteria, Probiotics, Prebiotics, and Phages | Q57816699 | ||
| Personalized Gut Mucosal Colonization Resistance to Empiric Probiotics Is Associated with Unique Host and Microbiome Features | Q57899618 | ||
| Post-Antibiotic Gut Mucosal Microbiome Reconstitution Is Impaired by Probiotics and Improved by Autologous FMT | Q57899622 | ||
| Targeting the microbiome: from probiotics to fecal microbiota transplantation | Q58095226 | ||
| Identification and antibiotic susceptibility of lactobacilli isolated from turkeys | Q58101267 | ||
| Role of the intestinal microbiome in autoimmune diseases and its use in treatments | Q58120865 | ||
| Probiotics as treatment for food allergies among pediatric patients: a meta-analysis | Q58693565 | ||
| Butyrate Producers as Potential Next-Generation Probiotics: Safety Assessment of the Administration of to Healthy Volunteers | Q58699938 | ||
| 'Brain Fogginess' and D-Lactic Acidosis: Probiotics Are Not the Cause | Q58700286 | ||
| Fermented Foods as a Dietary Source of Live Organisms | Q58705730 | ||
| Brain Fogginess and SIBO: A Link or Just a Mirage? | Q58712459 | ||
| GG in the Primary Prevention of Eczema in Children: A Systematic Review and Meta-Analysis | Q58723147 | ||
| Probiotic related endocarditis in a patient with liver cirrhosis | Q58766868 | ||
| Characterization of a Prophage-Free Derivative Strain of ssp. IL1403 Reveals the Importance of Prophages for Phenotypic Plasticity of the Host | Q58781118 | ||
| Expanding the reach of probiotics through social enterprises | Q58860894 | ||
| Probiotics can Cause D-Lactic Acidosis and Brain Fogginess: Reply to Quigley et al | Q59128875 | ||
| Recent advances in probiotics as live biotherapeutics against gastrointestinal diseases | Q59356765 | ||
| Myalgic Encephalomyelitis/Chronic Fatigue Syndrome in the Era of the Human Microbiome: Persistent Pathogens Drive Chronic Symptoms by Interfering With Host Metabolism, Gene Expression, and Immunity | Q60046972 | ||
| Microbial Transglutaminase Is Immunogenic and Potentially Pathogenic in Pediatric Celiac Disease | Q60960104 | ||
| DR7 alleviates stress and anxiety in adults: a randomised, double-blind, placebo-controlled study | Q64113267 | ||
| A novel immunostimulating aspect of Lactobacillus gasseri: induction of "Gasserokine" as chemoattractants for macrophages | Q74331326 | ||
| Contamination of probiotic preparations with milk allergens can cause anaphylaxis in children with cow's milk allergy | Q79706941 | ||
| Probiotic formulations and applications, the current probiotics market, and changes in the marketplace: a European perspective | Q80463729 | ||
| Antibiotic resistance and virulence traits in clinical and environmental Enterococcus faecalis and Enterococcus faecium isolates | Q84485494 | ||
| Next-generation probiotics: the spectrum from probiotics to live biotherapeutics | Q87909855 | ||
| Are probiotics effective in preventing urinary tract infection? | Q88291467 | ||
| Microbiota potential for the treatment of sexual dysfunction | Q88444421 | ||
| The ascent of the blessed: regulatory issues on health effects and health claims for probiotics in Europe and the rest of the world | Q88808683 | ||
| Influence of Probiotics Administration on Gut Microbiota Core: A Review on the Effects on Appetite Control, Glucose, and Lipid Metabolism | Q88973983 | ||
| The microbiome in autoimmune diseases | Q89152959 | ||
| Harms Reporting in Randomized Controlled Trials of Interventions Aimed at Modifying Microbiota: A Systematic Review | Q90264125 | ||
| Antimicrobial Susceptibility Testing and Tentative Epidemiological Cutoff Values for Five Bacillus Species Relevant for Use as Animal Feed Additives or for Plant Protection | Q90374115 | ||
| Microbial occurrence and antibiotic resistance in ready-to-go food items | Q90453721 | ||
| Horizontal gene transfer amongst probiotic lactic acid bacteria and other intestinal microbiota: what are the possibilities? A review. | Q37824816 | ||
| Immunology and probiotic impact of the newborn and young children intestinal microflora | Q37868347 | ||
| Virulence factors involved in the pathogenesis of the infection caused by the swine pathogen and zoonotic agent Streptococcus suis | Q37983135 | ||
| Why the European Food Safety Authority was right to reject health claims for probiotics | Q38017544 | ||
| Safety of probiotics used to reduce risk and prevent or treat disease. | Q38057789 | ||
| Health claim regulation of probiotics in the USA and the EU: is there a middle way? | Q38068984 | ||
| Potential impact of environmental bacteriophages in spreading antibiotic resistance genes | Q38108837 | ||
| Effects of genetic, processing, or product formulation changes on efficacy and safety of probiotics | Q38191262 | ||
| Dysbiosis May Trigger Autoimmune Diseases via Inappropriate Post-Translational Modification of Host Proteins | Q38264590 | ||
| The history of probiotics: the untold story | Q38313533 | ||
| Activation of rho through a cross-link with polyamines catalyzed by Bordetella dermonecrotizing toxin | Q38315380 | ||
| The Rho-deamidating cytotoxic necrotizing factor 1 from Escherichia coli possesses transglutaminase activity. Cysteine 866 and histidine 881 are essential for enzyme activity | Q38337026 | ||
| Changes in intestinal tight junction permeability associated with industrial food additives explain the rising incidence of autoimmune disease | Q38353318 | ||
| Review: The market of probiotics | Q38660252 | ||
| Induction of regulatory T cells: A role for probiotics and prebiotics to suppress autoimmunity. | Q38698750 | ||
| Integration of microbiome and epigenome to decipher the pathogenesis of autoimmune diseases | Q38739778 | ||
| Intestinal dysbiosis and probiotic applications in autoimmune diseases. | Q38757039 | ||
| Probiotics for people with hepatic encephalopathy | Q38946102 | ||
| Characterization of Antibiotic Resistance Genes from Lactobacillus Isolated from Traditional Dairy Products | Q38969458 | ||
| A Randomized Double Blind Controlled Safety Trial Evaluating d-Lactic Acid Production in Healthy Infants Fed a Lactobacillus reuteri-containing Formula | Q38970627 | ||
| Probiotics, D-Lactic acidosis, oxidative stress and strain specificity | Q39024657 | ||
| A review of dose-responses of probiotics in human studies. | Q39051304 | ||
| New insights in antibiotic resistance of Lactobacillus species from fermented foods | Q39256236 | ||
| Probiotic and synbiotic safety in infants under two years of age. | Q39264265 | ||
| Using probiotics in clinical practice: Where are we now? A review of existing meta-analyses. | Q39391152 | ||
| Prenatal and postnatal administration of prebiotics and probiotics | Q39442525 | ||
| Bacteriophages in the human gut: Our fellow travelers throughout life and potential biomarkers of heath or disease | Q39457977 | ||
| Incidence of virulence factors and antibiotic resistance among Enterococci isolated from food | Q39492663 | ||
| Characterization of two Bacillus probiotics | Q39528027 | ||
| Spontaneously induced prophages in Lactobacillus gasseri contribute to horizontal gene transfer | Q39539664 | ||
| Administration of two probiotic strains during early childhood does not affect the endogenous gut microbiota composition despite probiotic proliferation | Q40089670 | ||
| The human gut microbiome as source of innovation for health: Which physiological and therapeutic outcomes could we expect? | Q40354918 | ||
| Genomic Diversity of Phages Infecting Probiotic Strains of Lactobacillus paracasei. | Q40422574 | ||
| Probiotics History | Q40506900 | ||
| Safety of probiotics and synbiotics in children under 18 years of age. | Q41159908 | ||
| Stability evaluation of freeze-dried Lactobacillus paracasei subsp. tolerance and Lactobacillus delbrueckii subsp. bulgaricus in oral capsules. | Q41405263 | ||
| D-Lactic Acidosis in a Man with the Short-Bowel Syndrome | Q41644333 | ||
| The administration of probiotics and synbiotics in immune compromised adults: is it safe? | Q41705850 | ||
| D-lactic acidosis. A review of clinical presentation, biochemical features, and pathophysiologic mechanisms | Q41747246 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 4 | |
| P921 | main subject | probiotics | Q1816730 |
| P577 | publication date | 2019-04-11 | |
| P1433 | published in | Microorganisms | Q27725360 |
| P1476 | title | Probiotics: If It Does Not Help It Does Not Do Any Harm. Really? | |
| P478 | volume | 7 |
| Q89965676 | Feed, Microbiota, and Gut Immunity: Using the Zebrafish Model to Understand Fish Health |
| Q92642735 | Large Plasmid Complement Resolved: Complete Genome Sequencing of Lactobacillus plantarum MF1298, a Candidate Probiotic Strain Associated with Unfavorable Effect |
| Q90411008 | Probiotic Supplements: Hope or Hype? |
| Q89659555 | Processed Food Additive Microbial Transglutaminase and Its Cross-Linked Gliadin Complexes Are Potential Public Health Concerns in Celiac Disease |
| Q92814609 | The Revival of the Battle between David and Goliath in the Enteric Viruses and Microbiota Struggle: Potential Implication for Celiac Disease |
Search more.